Andrew Hykes - 04 Feb 2025 Form 4 Insider Report for Inari Medical, Inc.

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
04 Feb 2025
Net transactions value
$0
Form type
4
Filing time
06 Feb 2025, 16:47:52 UTC
Previous filing
03 Jan 2025
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Award $0 +67,282 +15% $0.000000 502,706 04 Feb 2025 Direct F1, F2
holding NARI Common Stock 1,550 04 Feb 2025 By Child 1
holding NARI Common Stock 1,550 04 Feb 2025 By Child 2
holding NARI Common Stock 1,550 04 Feb 2025 By Child 3
holding NARI Common Stock 1,000 04 Feb 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded to the reporting person, with a vesting commencement date of January 1, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
F2 Includes 523 shares acquired on January 31, 2025, under the Company's Employee Stock Purchase Plan.